Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Navan Inc. Class A Common Stock (NAVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Navan Inc. Class A Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.46 (market cap $6.04B), while Navan Inc. Class A Common Stock trades at $23.16 (market cap $6.01B). The key difference: Iovance Biotherapeutics Inc. Common Stock and Navan Inc. Class A Common Stock are close in size by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Navan Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Navan Inc. Class A Common Stock for 0 Days on average.
| IOVA | NAVN | |
|---|---|---|
Market Cap | $6.04B | $6.01B |
Volume | 14,805,993 | 2,990,425 |
Sector | Health | Technology |
52-Week High | $14.82 | $30.58 |
52-Week Low | $1.81 | $8.51 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $5.36B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Navan Inc. Class A Common Stock
Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →
